Relevant bibliographies by topics / HIV seronegative

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'HIV seronegative'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HIV seronegative.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HIV seronegative"

1

Majid, Ghinwa, Ahmed Abdulamir, Abbas Ahmed, Iman Aufi, and Orooba Abdullah. "The Using of Multiplex RT-qPCR for Pooled Samples to Detect Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus within Iraqi Blood Donors." Iraqi Journal of Medical Sciences 19, no. 1 (2021): 99–106. http://dx.doi.org/10.22578/ijms.19.1.13.

Full text
Abstract:
Background: The blood of blood donors is screening for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infection by enzyme immunoassay (EIA) in the National Center of Blood Bank in Baghdad. The residual risk of EIA negative samples is not estimated till now in Iraq. Objective: To detect HBV, HCV and HIV viruses within seronegative plasma of blood donors by a commercially available multiplex nucleic acid amplification tests (NAT) with mini-pooling system. Methods: One thousand (1000) blood donors were screened by EIA revealed negative results then NAT wa
APA, Harvard, Vancouver, ISO, and other styles
2

Cooper, Curtis L., Andrew D. Badley, and Jonathan B. Angel. "Characteristics of Hepatitis C Virus Infection in HIV-Infected People." Canadian Journal of Infectious Diseases 12, no. 3 (2001): 157–63. http://dx.doi.org/10.1155/2001/542056.

Full text
Abstract:
Knowledge pertaining to hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co-infection is currently incomplete or conflicting. Several points are well studied, however. Plasma HCV RNA levels are higher in matched HIV-infected people than in HIV-seronegative control subjects and are inversely correlated with CD4+T lymphocyte counts. HCV genotype does not appear to influence this value. Co-infected individuals develop histological and clinical features of HCV liver disease more rapidly than HIV-seronegative patients. Co-infected individuals appear to respond to interferon-alpha therapy
APA, Harvard, Vancouver, ISO, and other styles
3

Barros, M. F., J. Piedade, G. Nunes, et al. "Active replication of hepatitis B virus (HBV) in HIV type 1 and in HIV type 2 infected patients." Revista do Instituto de Medicina Tropical de São Paulo 38, no. 4 (1996): 253–58. http://dx.doi.org/10.1590/s0036-46651996000400003.

Full text
Abstract:
To evaluate the effect of concurrent infection by HIV on HBV infection or immunity, we have studied a group of 66 HIV1+ symptomatic Caucasian patients and another of 38 African HIV2+ asymptomatic individuals, concerning their HBV status: serological markers of infection and presence of HBV-DNA in serum, the last taken as sign of hepatitis B virus active replication, were monitored. HIV+ groups were compared with seronegative controls, adequately matched for age, sex and ethnological background. HBV DNA was found in 7.6% of HIV1+ Caucasian patients and 3.2% of seronegative controls; in African
APA, Harvard, Vancouver, ISO, and other styles
4

Behl, Shreya, Aaditya Behl, Pratibha Mane, Jyoti Sangwan, and Prakriti Vohra. "Seroprevalence of Hepatitis B and C co-infection in HIV seropositive and HIV seronegative cases in a Tertiary care hospital in Southern Haryana." IP International Journal of Medical Microbiology and Tropical Diseases 9, no. 2 (2023): 98–104. http://dx.doi.org/10.18231/j.ijmmtd.2023.019.

Full text
Abstract:
HBV (Hepatitis B virus) and HCV (Hepatitis C virus) are the causative agents of acute as well as chronic hepatitis. Nearly, two billion people are suffering with HBV and approximately 170 million people are infected with HCV infection around the world. While patients who are infected with HIV (Human Immunodeficiency Virus) 2-4 million are found to be having chronic HBV co-infection and 4-5 million are having HCV coinfection. Due to common mode of transmission of HIV, HBV and HCV like using shared needles, syringes, other injectable devices, sexual intercourse, or even mother to baby transmissi
APA, Harvard, Vancouver, ISO, and other styles
5

Lee, Chun-Yuan, Pei-Hua Wu, Meng-Wei Lu, Tun-Chieh Chen, and Po-Liang Lu. "High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan." PLOS ONE 16, no. 5 (2021): e0251158. http://dx.doi.org/10.1371/journal.pone.0251158.

Full text
Abstract:
Objectives HCV infection status awareness is crucial in the HCV care continuum for both HCV-seropositive (HCV-positive status awareness) and seronegative (HCV-negative status awareness) populations. However, trends in the unawareness of HCV infection status (UoHCV) remain unknown in HIV-positive patients. This study investigated UoHCV prevalence, the associated factors of UoHCV, and its association with HCV-related knowledge in HIV-positive patients. Methods For this cross-sectional, multicenter, questionnaire-based study, 844 HIV-infected participants were recruited from three hospitals in Ta
APA, Harvard, Vancouver, ISO, and other styles
6

Popa, Cristina, Carmen Gabriela Stelea, Ana Maria Filioreanu, et al. "PCR Analysis of the Herpesviruses Presence in Crevicular Fluid in HIV- Positive Patients." Revista de Chimie 68, no. 11 (2017): 2672–75. http://dx.doi.org/10.37358/rc.17.11.5951.

Full text
Abstract:
The present study aimed to determine the frequency of herpesviruses in gingival fluid samples in patients with periodontitis HIV compared to HIV-negative subjects. Gingival crevicular fluid samples were obtained from 28 patients with HIV-positive periodontitis and from 14 patients with HIV seronegative periodontitis. Herpesviruses have been identified by PCR amplification methods. In HIV-positive patients, the most prevalent herpes virus was HCMV, followed by HHV-6 and HHV-7. In non-HIV-related periodontitis, HCMV was identified in 11 samples and EBV-1 in 8 samples, followed by HSV (7 samples)
APA, Harvard, Vancouver, ISO, and other styles
7

Levin, A., G. Brubaker, J. S. Shao, et al. "Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals." International Journal of STD & AIDS 7, no. 4 (1996): 288–91. http://dx.doi.org/10.1258/0956462961917825.

Full text
Abstract:
With the FACSCount TM flow cytometer, counts of CD4, CD8 and CD3 lymphocytes and CD4/CD8 ratios were performed in a rural hospital in Tanzania. A total of 168 subjects (21 HIV-1 seropositive and 147 HIV-1 seronegative) were tested as part of a population-based serosurvey and AIDS education programme; 134 other subjects were hospitalized patients who had signs and symptoms suggestive of AIDS (69 HIV-1 seropositive and 65 HIV-seronegative). Mean values for the 147 HIV-1 seronegative subjects from the local population were 980 CD4 cells (95% CI 930, 1031), 598 CD8 cells (560, 635) and CD4/CD8 rat
APA, Harvard, Vancouver, ISO, and other styles
8

Simakawa, Raquel M., Beatriz C. Araújo, Erika Ono, M. Isabel De Moraes-Pinto, and Regina C. M. Succi. "Measles seroprevalence in adolescents and young adults living with HIV and response to MMR booster in seronegative ones." AIDS 38, no. 1 (2023): 123–25. http://dx.doi.org/10.1097/qad.0000000000003720.

Full text
Abstract:
Objective: The study analyzed people with HIV (PWH) measles seroprevalence and response to MMR booster given to seronegative individuals. Design: A prospective cohort study with four groups: vertically (v-HIV), horizontally infected (h-HIV) individuals, and two control groups. An MMR booster was offered to seronegative individuals. Results: Measles seropositivity and IgG antibodies were significantly lower in v-HIV than in the other groups. All measles seronegative patients responded to booster. Conclusion: An MMR booster must be sought during adolescence in vertically PWH.
APA, Harvard, Vancouver, ISO, and other styles
9

Ichimura, H., J. M. Dwyer, H. Tsuchie, et al. "Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals." International Journal of STD & AIDS 8, no. 5 (1997): 307–10. http://dx.doi.org/10.1258/0956462971920145.

Full text
Abstract:
The inhibitory effect of CD8+ T-cells from HIV-infected or HIVseronegative individuals on HIV replication in the naturally-infected CD4+ T-cells in vitro was examined. Not only autologous CD8+ T-cells from HIV-infected individuals but also allogeneic CD8+ T-cells from HIV-seronegative individuals prevented or delayed HIV replication, even in transwell cocultures using a semipermeable 0.45 micron filter. The level of the inhibitory effect of allogeneic CD8+ Tcells from the HIV-seronegative individuals on the HIV replication was varied among CD4+ T-cells obtained from HIV-infected individuals us
APA, Harvard, Vancouver, ISO, and other styles
10

Martin, Troy M., and Josiah D. Rich. "Fatal HIV Encephalitis in HIV-Seronegative Patients." Emerging Infectious Diseases 15, no. 1 (2009): 129–31. http://dx.doi.org/10.3201/eid1501.070834.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HIV seronegative"

1

Speelmon, Emily. "Innate mechanisms of HIV-1 protection in highly exposed, seronegative individuals /." Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/4998.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tab, Su-ming Stella Veronica. "Myelopathies in human immunodeficiency virus (HIV) infection : a clinical and pathological study with particular reference to the pathogenesis of vascular myelopathy." Thesis, University College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sarrazin, Heike. "The immunregulation of the Tuberculin skin test in HIV-seropositive and HIV-seronegative persons." Lübeck Zentrale Hochschulbibliothek Lübeck, 2010. http://d-nb.info/1000297837/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Watson, Scott C. A. "Coping with the HIV and AIDS epidemic in HIV seronegative gay males in Montreal." Thesis, McGill University, 1999. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36849.

Full text
Abstract:
One hundred nine HIV seronegative gay (HSG) males from the Montreal gay community, drawn from downtown health clinics, advertisements in gay friendly newspapers, and referrals from colleagues, were examined with respect to how they were coping with the HIV and AIDS epidemic (July 3, 1981 to August, 1998). Participants were asked to complete both a detailed demographic questionnaire and the Ways of Coping Questionnaire. Coping theory and coping research relevant to the research at hand are discussed in detail. Results indicate that HSG males in Montreal are coping most frequently with the HIV a
APA, Harvard, Vancouver, ISO, and other styles
5

Sarrazin, Heike [Verfasser]. "The immunregulation of the Tuberculin skin test in HIV-seropositive and HIV-seronegative persons / Heike Sarrazin." Lübeck : Zentrale Hochschulbibliothek Lübeck, 2010. http://d-nb.info/1000297837/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Campion, Suzanne L. "Detection and characterization of HIV-1 specific T cell responses amongst exposed and unexposed HIV-1 seronegative individuals." Thesis, University of Oxford, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.558213.

Full text
Abstract:
The primary aim of this thesis was to examine whether HIV -1 specific T cell responses in HIV -1 exposed seronegative (HESN) subjects could be firstly detected and if so, conferred protection against productive infection from HIV -1. Cultured IFN-y ELISpot found 38.7-60% of HESN subjects had detectable HIV-1 specific T cell responses. HIV -1 specific T cell responses could be titrated, were typically mediated by CD4+ T cells and tended to map to previously defined, promiscuous epitopes. In a statistically powered, retrospective study, no evidence was found to support a role for pre-existing HI
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Yanmin. "The mucosal immunity in HIV-1 exposed seronegative individuals and expression of HIV-1 gp160 protein in transgenic plants." Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/12419.

Full text
Abstract:
The aim of this thesis was firstly to investigate the possibility of local antibody in urine samples from HEPS individuals to evaluate the theory that such individuals may develop a protective local anti-HIV-l antibody response, detectable in urine. Since elicitation of mucosal immunity is important in preventing viral infection by sexual transmission, development of a vaccine which is effective for the induction of mucosal immune responses may provide protection to mucosal surfaces against HIV-1 transmission. Transgenic plants expressing foreign protein has been demonstrated to be an inexpens
APA, Harvard, Vancouver, ISO, and other styles
8

Rahman, Syeda Sharmin. "Measurement and characterization of HIV inhibitory Clade A Serpins in the cervical mucosa of highly HIV-1 exposed seronegative individuals." American Chemical Society (ACS) Publications, 2011. http://hdl.handle.net/1993/5065.

Full text
Abstract:
Objective: Serpins are serine protease inhibitors that are involved in a wide variety of biological functions in nature. They are known to regulate inflammation processes as well as provide host defense against microorganisms. Recent evidence has associated many types of mucosal serpins with a protective phenotype against HIV infection in women. Our hypothesis is that serpins with known antiviral activity against HIV-1 are correlated with protection in a group of HIV exposed seronegative individuals (HIV-resistant) from the Pumwani sex worker cohort. Study design: Cervico-vaginal lavage (CV
APA, Harvard, Vancouver, ISO, and other styles
9

Malaza, Abraham Lucky. "Studies on multiply exposed but persistently HIV-1 seronegative sex workers from KwaZulu/Natal, South Africa." Master's thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/24941.

Full text
Abstract:
The overall aim of this study was to determine whether host genetic factors are associated with resistance to HIV-1 infection in a group of highly exposed persistently seronegative sex workers from KwaZulu/Natal, South Africa. A cohort of 17 African highly exposed but persistently seronegative (HEPS) commercial sex workers (CSW) were identified who had been in sex work for more than four years (range between 4-26 years). The women had been followed monthly for at least four years as part of HIV-1 prevention programmes (Ramjee, et al., 1998). The overall aim of this study was to identify the fr
APA, Harvard, Vancouver, ISO, and other styles
10

Cheng, Wei-Woon Susan. "Sociodemographic and drug use characteristics, sex behaviors, and motivations for drug use among HIV-seronegative, heterosexual, methamphetamine users in San Diego, CA." Diss., [La Jolla, Calif.] : [San Diego] : University of California, San Diego ; San Diego State University, 2009. http://wwwlib.umi.com/cr/ucsd/fullcit?p3355791.

Full text
Abstract:
Thesis (Ph. D.)--University of California, San Diego, and San Diego State University, 2009.<br>Title from first page of PDF file (viewed June 25, 2009). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HIV seronegative"

1

Hughes, Edward, Miles Stanford, and Dania Qatarneh. Uveitis and medical ophthalmology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199672516.003.0007.

Full text
Abstract:
This chapter focuses on uveitis and medical ophthalmology. It details uveal anatomy, before discussing anterior uveitis, intermediate uveitis, and posterior uveitis. Next, it discusses posterior uveitis and then specific non-infectious posterior uveitides before moving on to infectious uveitis (viral, parasitic, fungal, and bacterial) and HIV-related disease. It continues by examining systemic associations with uveitis, including sarcoidosis, Behcets disease, multiple sclerosis, and the seronegative arthritides ankylosing spondylitis, Reiter syndrome, psoriatic arthritis, and inflammatory bowe
APA, Harvard, Vancouver, ISO, and other styles
2

Berlin, Freie Universität, ed. Die kontrollierte Hyperventilation bei der Ableitung des Elektroenzephalogramms: Methodik und Ergebnisse (HIV-infizierte Patienten in verschiedenen Stadien der Infektion und HIV-seronegatives Kontrollkollektiv). 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "HIV seronegative"

1

Akinyosoye, A. D., M. I. Oniha, T. J. Oduselu, J. A. Akinbo, and Paul Akinduti. "Implication of Age-Demography of Mycobacterium tuberculosis Infection Among HIV-Seropositive and HIV-Seronegative Individuals." In Biotechnological Approaches to Sustainable Development Goals. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-33370-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Weigel, M. "Determinanten des Infektionsrisikos HIV seronegativer Frauen." In 54. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-18257-0_160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

von Depka Prondzinski, M., A. Berger, I. Scharrer, and B. Weber. "Chronische Hepatitis C, HCV-Virämie und HCV-Genotyp bei HIV-seropositiven und HIV-seronegativen Hämophilen." In 25. Hämophilie-Symposion Hamburg 1994. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-79648-7_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brookmeyer, Ron, and Mitchell H. Gail. "Risk Factors for Infection and the Probability of HIV Transmission." In AIDS Epidemiology: A Quantitative Approach. Oxford University PressNew York, NY, 1994. http://dx.doi.org/10.1093/oso/9780195076417.003.0002.

Full text
Abstract:
Abstract In this chapter, we describe several types of observational studies that were used to define behaviors and other factors associated with increased risk of HIV infection and AIDS. Careful interview of individual patients with AIDS identified the major modes of transmission. Case-control studies comparing patients with AIDS to subjects without AIDS further delineated behaviors and other factors associated with increased risk of AIDS. When assays for antibody to HIV became available in 1984, investigators classified populations into seropositive people with prevalent HIV infections and s
APA, Harvard, Vancouver, ISO, and other styles
5

Jehuda-Cohen, Tamar. "The HIV Seronegative Window Period: Diagnostic Challenges and Solutions." In Recent Translational Research in HIV/AIDS. InTech, 2011. http://dx.doi.org/10.5772/19402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nienow, John R., and David H. Spach. "Varicella-Zoster Virus." In The HIV Manual. Oxford University PressNew York, NY, 1996. http://dx.doi.org/10.1093/oso/9780195100365.003.0039.

Full text
Abstract:
Abstract Varicella-zoster virus is a DNA herpes virus. More than 90 percent of adults have serologic evidence of infection with varicella-zoster virus. Therefore, primary varicella infection infrequently occurs among HIV-infected adults. There is a high incidence of zoster in association with HIV infection: one study (Buchbinder et al., 1992) has shown that when compared with age-matched HIV- seronegative men, the relative risk of developing zoster among HIV-infected men is approximately 17. In addition, 8 to 12 percent of AIDS patients develop zoster at least once. Recurrent episodes of zoste
APA, Harvard, Vancouver, ISO, and other styles
7

Durand, Christine M. "Solid Organ Transplantation in Persons with HIV." In Fundamentals of HIV Medicine 2023. Oxford University PressNew York, 2023. http://dx.doi.org/10.1093/med/9780197679098.003.0022.

Full text
Abstract:
Abstract Until recently, people living with HIV were largely excluded from consideration of solid organ transplantation because of concerns regarding limited life expectancy and less favorable survival and graft outcomes. The HIV Organ Policy Equity Act allows use of organs from donors with HIV to be used for transplant for recipients with HIV under research protocols. Significant progress has been made in HIV D+/R + transplantation such that data demonstrate patient and graft survival rates in kidney transplant recipients with HIV are equivalent to that of seronegative kidney recipients, and
APA, Harvard, Vancouver, ISO, and other styles
8

Kovach, Nicholas L., Laura A. Koutsky, and Nancy B. Kiviat. "Anal Neoplasia." In The HIV Manual. Oxford University PressNew York, NY, 1996. http://dx.doi.org/10.1093/oso/9780195100365.003.0059.

Full text
Abstract:
Abstract Human papillomavirus virus (HPV) is a common sexually transmitted agent. HPV infection is associated with intraepithelial neoplasia, the presumed precursor for anal cancer. Types 16, 18, and 31 are the types most frequently associated with malignancy, although other types, including 6 and 11, may also be associated with malignant dysplastic changes in HIV-infected persons. Southern DNA hybridization studies of anal specimens have shown a prevalence of 50 to 60 percent of HPV among HIV-infected individuals compared with only 20 to 30 percent among homosexual subjects not infected with
APA, Harvard, Vancouver, ISO, and other styles
9

Cohen, Mary Ann, and Harold W. Goforth. "Strategies for Primary and Secondary Prevention of HIV Transmission." In Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.003.0009.

Full text
Abstract:
Since HIV disease was first recognized three decades ago, numerous efforts have been made to prevent its continued transmission. The Centers for Disease Control and Prevention (CDC) estimates that more than 56,000 Americans become infected each year—one person every 9 1/2 minutes—and that more than one million people in this country are now living with HIV (CDC, 2008, 2009;Hall et al., 2008). The CDC estimates that roughly 1 in 5 people infected with HIV in the United States is unaware of his or her infection and may be unknowingly transmitting the virus to others (CDC, 2008). Over the past 15
APA, Harvard, Vancouver, ISO, and other styles
10

Goforth, Harold W., and Mary Ann Cohen. "Symptoms Associated with HIV and AIDS." In Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.003.0013.

Full text
Abstract:
Many persons with HIV and AIDS have symptoms that are unrelated to underlying psychiatric disorders but may masquerade as such. These symptoms may include insomnia, fatigue, nausea, or other troubling symptoms, and often result in suffering for patients, their families, and loved ones. The symptoms are common throughout the course of HIV and AIDS, from onset of infection to late-stage and end-stage AIDS. They need to be addressed whenever they occur and not only as part of end-of-life care. We present protocols to ameliorate or eliminate these symptoms and alleviate suffering. Fatigue is one o
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HIV seronegative"

1

Mariani, G., R. Ghirardini, P. Verani, et al. "ANTI-HIV AFTER HEATED CLOTTING FACTOR CONCENTRATES IN HEMOPHILIACS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643971.

Full text
Abstract:
In Italy, heated concentrates became the only source of hemophilia therapy since July 1985, when a government act enforced their use instead of nonheated concentrates. Since then 63 anti-HIV seronegative hemophiliacs treated with heated concentrates were followed-up prospectively, focusing on the development of anti-HIV. Anti-HIV (documented by persistent positivity for ELISA and WB) occurred in 6 patients who had no other risk factor for HIV infection. For 3, anti-HIV was first found in Sept., Oct. or Nov. 1985 i.e. within 4 months of the last infusion of unheated concentrates (July 1985). Fo
APA, Harvard, Vancouver, ISO, and other styles
2

Schimpf, Kl, H. H. Brackmann, D. Bock, G. Landbeck, E. Lechler, and H. Vinazzer. "NO ANTI-HIV SEROCONVERSION AFTER REPLACEMENT THERAPY WITH STEAM-TREATED FACTOR VIII CONCENTRATE. A STUDY OF 60 PATIENTS WITH HEMOPHILIA A AND VON WILLEBRAND'S DISEASE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644054.

Full text
Abstract:
Transmission of hepatitis viruses and HIV has proven to be a risk of replacement therapy. Since Dec. 1983 factor VIII concentrates in which viruses are inactivated by steam-treatment (Factor VIII TIM 3 or S-TIM 3) are available for therapy. As they are manufactured by 80% from US plasma it was necessary to prove that they do not transmit HIV. For ethical reasons it is not possible to treat control groups of patients with non-virus- inactivated concentrate. Non-transmission of HIV can, therefore, only be proven if anti-HIV seroconversion does not occur in larger groups of patients treated with
APA, Harvard, Vancouver, ISO, and other styles
3

Barcellos, Ana Carolina, Nathalia Zorze Rossetto, and Cristina de Oliveira Rodrigues. "Lb3.262 Late postnatal hiv mother to child transmission through breastfeeding: analysis of infant cases of previously seronegative mothers infected during lactation." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pasi, K. J., and F. G. H. Hill. "NO EVIDENCE OF HEPATITIS OR HIV TRANSMISSION IN VIRGIN HAEMOPHILIC BOYS TREATED WITH BRITISH HEAT TREATED FACTOR VIII CONCENTRATE (8Y)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643972.

Full text
Abstract:
HIV and hepatitis virus transmission is of major concern with factor VIII therapy. Non-A, non-B hepatitis (NANBH) has a near 100% incidence in patients previously treated with unheated large pool factor VIII concentrates. NHS heated high purity factor VIII concentrate (8Y) undergoes severe protracted heat treatment of the freeze dried concentrate theoretically sufficient to inactivate hepatitis viruses as well as HIV. Infusions of 22 different batches of 8Y have been given to 18 children with haemophilia A (10 virgin patients; 8 who had only received single donor cryoprecipitate) have been tre
APA, Harvard, Vancouver, ISO, and other styles
5

Pompermaier, Carolina, Cassio Fernando Paganini, Willian Ely Pin, Mateus Xavier Schenato, and Tales Antunes Franzini. "TUBERCULOUS LYMPHADENITIS: A CASE REPORT." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1079.

Full text
Abstract:
Tuberculous lymphadenitis is the infection of lymph nodes by Mycobacterium tuberculosis. In the USA, about 8.5% of the cases of tuberculosis (TB) were characterized by lymphadenitis. The peak occurs between 30 and 40 years of age, primarily in women. Extrapulmonary TB is usually diagnosed in immunocompromised patients. The diagnosis is given by positivity in the AFB (Alcohol-Acid Resistant Bacillus) in Ziehl-Neelsen staining by sample collected by fine-needle puncture or lymph node excision. Cyto and histological analysis demonstrate epithelial cells, caseous necrosis, and necrotic cells. Such
APA, Harvard, Vancouver, ISO, and other styles
6

Campos, M., L. Santos, J. Lobato, C. Melo, and B. Justica. "HTLV III/LAV ANTIBODY STATUS, AND IMMUNOLOGICAL ABNORMALITIES IN A HEMOPHILIC POPULATION FROM PORTUGAL Campos." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644143.

Full text
Abstract:
An immunological study in a population of 46 hemophiliacs (A and B)under replacement therapy mainly with cryo, plasma and eventually withccmercial concentrates was carried out to detect changes related to HTLV III infection and those due totreatment. We followed the patients during 85-87 and we evaluate the abnormalities over a period of 2 years . Methods. Ig's (nephelometry): total lymphocytes, T3, T4, T8 subsets and B cells (IF microcopy):delayed hypersensivity skin tests (DHST) ,7 antigens: serology for HTLV III (ELISA and WB) (β 2 microglobulin (ELISA) Results. In 85,10 patients had anti H
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'HIV seronegative' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography